F573 Ia Clinical Trial

Clinical trial NCT04820049 · COMPLETED

Trial details

NCT number: NCT04820049
Sponsor: Beijing Continent Pharmaceutical Co, Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Tolerance Pharmacokinetic

Start date: 2021-02-08
Primary completion: 2022-08-02
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.